T-Cypher Bio

0 followers


T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targ... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Thomas L. Andresen
Chief Executive Officer

Thomas L. Andresen

Collapse
Hemza Ghadbane
Senior Director
Mark Lees
VP Corporate Development
Nathaniel Davies
Senior Director Computational Biology
Sarah Leonard
Vice President, Pre-clinical Development